These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8436640)

  • 1. Dermatitis in treated maple syrup urine disease.
    Koch SE; Packman S; Koch TK; Williams ML
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 2):289-92. PubMed ID: 8436640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional deficiency dermatitis related to branched-chain amino acid restriction in a child with maple syrup urine disease.
    Campuzano-García AE; Castanedo-Cázares JP
    Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroencephalograms in a case of maple syrup urine disease: their relation to serum levels of branched-chain amino acids.
    Iinuma K; Saito T; Wada Y; Onuma A; Takamatsu N
    Tohoku J Exp Med; 1976 Oct; 120(2):191-5. PubMed ID: 982436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolated isoleucine deficiency in diet therapy of a case of maple syrup urine disease].
    Sanjurjo P; Centeno C; Vallo A; Ojembarrena E; Rodríguez Soriano J
    An Esp Pediatr; 1983 Nov; 19(5):389-92. PubMed ID: 6660656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrodermatitis enteropathica-like syndrome secondary to isoleucine deficiency during treatment of maple syrup urine disease.
    Giacoia GP; Berry GT
    Am J Dis Child; 1993 Sep; 147(9):954-6. PubMed ID: 8362810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maple syrup urine disease. Two cases in Israel.
    Chemke J; Levin S
    Isr J Med Sci; 1975 Aug; 11(8):809-16. PubMed ID: 1165176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic study of the classic form of leucinosis during exchange transfusion therapy].
    Zeman J; Hyánek J; Houstková H; Rubín A; Verner P; Pehal F; Konecná L; Zapadlo M; Plavka R; Wendel U
    Cesk Pediatr; 1987 Apr; 42(4):219-22. PubMed ID: 3594613
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective study of maple-syrup-urine disease for the first four days of life.
    DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
    N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
    [No Abstract]   [Full Text] [Related]  

  • 10. Dietary management of maple-sirup-urine disease: extension of equivalency systems.
    Bell L; Chao E; Milne J
    J Am Diet Assoc; 1979 Mar; 74(3):357-61. PubMed ID: 762364
    [No Abstract]   [Full Text] [Related]  

  • 11. [Leucinosis: study of a case].
    Moura-Ribeiro MV; Funayama CA
    Arq Neuropsiquiatr; 1985 Dec; 43(4):403-6. PubMed ID: 3833142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria.
    Parsons HG; Carter RJ; Unrath M; Snyder FF
    J Inherit Metab Dis; 1990; 13(2):125-36. PubMed ID: 2116544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiquantitation of leucine, isoleucine, and valine by thin-layer chromatography in management of maple-syrup urine diseases.
    Allen RJ; Frey HJ; Fleming LM; Owings CL
    Clin Chem; 1972 May; 18(5):413-6. PubMed ID: 5019114
    [No Abstract]   [Full Text] [Related]  

  • 14. [Maple syrup urine disease. (Valine-leucine-uria)].
    Platt D; Beneke G; Peiffer J; Schmidt GW
    Med Welt; 1966 May; 19():1089-93. PubMed ID: 5974899
    [No Abstract]   [Full Text] [Related]  

  • 15. Maple syrup urine disease. Four years' experience with dietary treatment of a case.
    Dickinson JP; Holton JB; Lewis GM; Littlewood JM; Steel AE
    Acta Paediatr Scand; 1969 Jul; 58(4):341-51. PubMed ID: 5824823
    [No Abstract]   [Full Text] [Related]  

  • 16. A dermatitis secondary to amino-acid deficiency in treated maple syrup urine disease.
    Koch SE; Koch TK; Williams ML
    Arch Pediatr Adolesc Med; 1994 Sep; 148(9):993-4. PubMed ID: 7802785
    [No Abstract]   [Full Text] [Related]  

  • 17. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children].
    Kowalik A; Narojek L; Sykut-Cegielska J
    Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dietary treatment of maple syrup urine diseases].
    Guibaud P; de Parscau L; Guffon N; Laval MC
    Pediatrie; 1993; 48(10):681-6. PubMed ID: 8015866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation.
    Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE
    Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474
    [No Abstract]   [Full Text] [Related]  

  • 20. Corneal deepithelialization caused by acute deficiency of isoleucine during treatment of a patient with maple syrup urine disease.
    Tornqvist K; Tornqvist H
    Acta Ophthalmol Scand Suppl; 1996; (219):48-9. PubMed ID: 8741119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.